Mehdi Nassiri Selected Research

Mehdi Nassiri Research Topics

Disease

11	Neoplasms (Cancer) 03/2022 - 02/2003
5	Prolapse 10/2010 - 11/2008
3	Uterine Prolapse (Vaginal Prolapse) 10/2010 - 05/2009
2	Breast Neoplasms (Breast Cancer) 12/2008 - 01/2008
2	Mixed Connective Tissue Disease (MCTD) 06/2008 - 02/2006
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	Plasmablastic Lymphoma 01/2022
1	Insulin Resistance 01/2022
1	Obesity 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Primary Effusion Lymphoma 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Cysts 10/2021
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 12/2020
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2020
1	Leukocytosis (Pleocytosis) 01/2020
1	Eosinophilia 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2014
1	Leukemia 10/2014
1	Myeloid Sarcoma (Chloroma) 10/2014
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2014
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2014
1	Infectious Mononucleosis (Glandular Fever) 01/2014
1	Cicatrix (Scar) 02/2009
1	Keloid 02/2009
1	Pelvic Organ Prolapse 02/2009
1	Leg Ulcer 11/2008
1	Nephritis 05/2007
1	Autoimmune Diseases (Autoimmune Disease) 05/2007
1	Sialadenitis 05/2007
1	Malignant Fibrous Histiocytoma 06/2006
1	Benign Fibrous Histiocytoma (Dermatofibroma) 06/2006
1	Dermatofibrosarcoma 06/2006
1	Glomerulonephritis 02/2006
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2006
1	Lung Diseases (Lung Disease) 02/2006
1	Thrombotic Thrombocytopenic Purpura 06/2005
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2003
1	Erythema 10/2003
1	Pathologic Processes 09/2003
1	Islet Cell Adenoma (Islet Cell Tumors) 02/2003

Drug/Important Bio-Agent (IBA)

6	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2007
4	Messenger RNA (mRNA)IBA 10/2010 - 02/2009
3	CytokinesIBA 02/2009 - 10/2003
2	Complementary DNA (cDNA)IBA 01/2022 - 11/2008
2	DNA (Deoxyribonucleic Acid)IBA 08/2016 - 01/2008
2	Proteins (Proteins, Gene)FDA Link 06/2010 - 01/2008
2	Calmodulin-Binding Proteins (Caldesmon)IBA 06/2010 - 08/2009
2	Estrogen ReceptorsIBA 12/2008 - 01/2008
2	U1 small nuclear RNAIBA 06/2008 - 02/2006
2	AutoantigensIBA 06/2008 - 02/2006
2	Small Nuclear Ribonucleoproteins (snRNP)IBA 06/2008 - 02/2006
2	AntibodiesIBA 06/2006 - 02/2006
1	tagraxofuspIBA 03/2022
1	Anaplastic Lymphoma KinaseIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	VimentinIBA 01/2022
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2022
1	Cyclin D1IBA 10/2021
1	Thyroglobulin FDA Link 10/2021
1	Colloids (Colloid)IBA 10/2021
1	TOR Serine-Threonine KinasesIBA 12/2020
1	Imatinib Mesylate (Gleevec)FDA Link 01/2020
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2014
1	R-CHOP protocolIBA 10/2014
1	Indicators and Reagents (Reagents)IBA 10/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2014
1	Vincristine (Oncovin)FDA LinkGeneric 10/2014
1	Prednisone (Sone)FDA LinkGeneric 10/2014
1	Rituximab (Mabthera)FDA Link 10/2014
1	Immunoglobulin M (IgM)IBA 01/2014
1	CaspasesIBA 02/2009
1	Phosphotransferases (Kinase)IBA 02/2009
1	fibulinIBA 02/2009
1	Caspase 6IBA 02/2009
1	Caspase 14IBA 02/2009
1	EpitopesIBA 06/2008
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 06/2008
1	Formaldehyde (Formol)FDA Link 01/2008
1	Fixatives (Pickling Agents)IBA 01/2008
1	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2007
1	SS-A antigen (Ro antigen)IBA 05/2007
1	ProteomeIBA 08/2006
1	S100 Proteins (S 100 Protein)IBA 06/2006
1	Factor XIIIaIBA 06/2006
1	DesminIBA 06/2006
1	Keratins (Keratin)IBA 06/2006
1	thiamine triphosphorate (TTP)IBA 06/2005
1	Interleukin-12 (IL 12)IBA 10/2003
1	Interleukin-8 (Interleukin 8)IBA 10/2003
1	ImmunosorbentsIBA 10/2003
1	EnzymesIBA 10/2003
1	Protein Isoforms (Isoforms)IBA 09/2003

Therapy/Procedure

4	Therapeutics 08/2016 - 11/2008
2	Hysterectomy 05/2009 - 11/2008
1	Immunotherapy 03/2022
1	Precision Medicine 08/2016
1	Drug Therapy (Chemotherapy) 12/2008
1	Plasma Exchange 06/2005